Recombinant humanized type iii collagen high expression design and industrialized preparation and application
Patent Information
- Application Number
- CN202311598774.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-28
- Publication Date
- 2026-09-15
- Estimated Expiration
- 2043-11-28
AI Technical Summary
[0006]然而,上述现有技术公开的重组人源Ⅲ型胶原蛋白虽然产量有所提高,但是仍然难以达到工业化大规模生产的水平
[0033]1. 现有技术中的重组人源Ⅲ型胶原蛋白存在产量低的缺陷,本发明酵母发酵表达的重组类人源Ⅲ型胶原蛋白COL3A1-6具有工业化生产水平的高产量,即诱导72 h发酵产物表达量可以达到15 g/L。与现有技术的类人源化Ⅲ型胶原蛋白COL3A1-QS-1进行产量比较,同等条件下进行发酵表达,本发明的重组类人源Ⅲ型胶原蛋白COL3A1-6是现有技术COL3A1-QS-1表达量的三倍,适合工业化大规模生产。
Smart Images

Figure CN117430691B_ABST
Abstract
Claims
1. A recombinant human-like type III collagen, named COL3A1-6, characterized in that, The amino acid sequence of the recombinant human type III collagen is shown in SEQ ID NO:
1.
2. An isolated nucleic acid, characterized in that, The recombinant human type III collagen of claim 1 is encoded.
3. The nucleic acid according to claim 2, characterized in that, The nucleic acid sequence is shown in SEQ ID NO:
2.
4. A recombinant vector, characterized in that, It contains the nucleic acid described in claim 2 or 3.
5. A recombinant host cell, characterized in that, It comprises the nucleic acid of claim 2 or 3, or the recombinant vector of claim 4.
6. A composition, characterized in that, It comprises the recombinant human type III collagen of claim 1, the nucleic acid of claim 2 or 3, the recombinant vector of claim 4, or the recombinant host cell of claim 5.
7. The composition according to claim 6, characterized in that, The composition is a lyophilized powder.
8. A method for preparing the recombinant human type III collagen of claim 1 by fermentation expression, characterized in that, The method includes seed culture, fermentation culture, and preparation of fermentation supernatant; wherein the seed is a seed culture of a glycerol strain of Pichia pastoris engineered strain encoding the target gene of recombinant human type III collagen as described in claim 1.
9. The method according to claim 8, characterized in that, The method includes the following steps: (1) Seed culture, wherein the seed is a seed culture of a glycerol strain of Pichia pastoris engineered strain containing the target gene encoding the recombinant human type III collagen of claim 1; (2) Fermentation culture: The seed culture is inoculated into the fermentation medium and cultured in a fermenter. The appropriate DO, stirring speed, aeration rate and temperature are controlled. Methanol is added at the appropriate growth stage to induce expression. (3) Preparation of fermentation supernatant: After culturing for a suitable time, the fermentation broth is taken to remove the cells, filtered, and fermentation supernatant is obtained.
10. A method for purifying the recombinant human type III collagen of claim 1, characterized in that, The method includes the step of ultrafiltration and concentration of the fermentation supernatant of the recombinant human type III collagen to obtain purified recombinant human type III collagen.
11. A method for preparing the lyophilized powder of the recombinant human type III collagen as described in claim 1, characterized in that, The method includes pre-lyophilizing the purified recombinant human type III collagen, and then lyophilizing it.
12. The use of the recombinant human type III collagen of claim 1, the nucleic acid of claim 2 or 3, the recombinant vector of claim 4, or the recombinant host cell of claim 5 in any of the following: (1) Preparation of functional cosmetics; (2) To prepare medical aesthetic cosmetics; or, (3) Preparation of medical dressings.
Citation Information
Patent Citations
Recombinant human-like collagen III and application thereof
CN116535494A
A recombinant humanized type III collagen, its preparation method and application
CN116640206B
Human-derived III-type collagen and preparation method thereof
CN116854808A
Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
CN107223019A
Polypeptide, and production method and application thereof
CN109593126A